P5 Patients with obstetric antiphospholipid syndrome have constitutively higher complement activation compared to healthy controls

P5 Patients with obstetric antiphospholipid syndrome have constitutively higher complement activation compared to healthy controls

Bibliographic Details
Main Authors:	Andrea Doria, Margherita Zen, Marta Tonello, Maria Favaro, Ilenia Anna Gennaio, Filippo Vesentini, Federico Arru, Claudio Cruciani, Merra Noemi, Teresa Del Ross, Antonella Calligaro
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2024-03-01
Series:	Lupus Science and Medicine

Similar Items

P73 Predictors of flares after glucocorticoid discontinuation in remitted patients with SLE
by: Andrea Doria, et al.
Published: (2024-03-01)

P72 Glucocorticoid discontinuation after remission achievement in not associated with an increased risk of flares
by: Andrea Doria, et al.
Published: (2024-03-01)

P143 Efficacy of consultation before and during pregnancy on therapeutic adherence surveyed in a single-center cohort of patients with rheumatic disease
by: Andrea Doria, et al.
Published: (2024-03-01)

P26 In remitted SLE patients BAFF/BLyS serum levels measured at the time of immunosuppressant discontinuation are higher in patients with subsequent flares
by: Andrea Doria, et al.
Published: (2024-03-01)

P79 Clinical features and prevalence of late and very late onset systemic lupus erythematosus
by: Andrea Doria, et al.
Published: (2024-03-01)

Low Preconception Complement Levels Are Associated with Adverse Pregnancy Outcomes in a Multicenter Study of 260 Pregnancies in 197 Women with Antiphospholipid Syndrome or Carriers of Antiphospholipid Antibodies
by: Cecilia Nalli, et al.
Published: (2021-06-01)

Differences in Antiphospholipid Antibody Profile between Patients with Obstetric and Thrombotic Antiphospholipid Syndrome
by: Ariadna Anunciación-Llunell, et al.
Published: (2022-10-01)

Natural killer cells in obstetric antiphospholipid syndrome
by: Rongxiu Huo, et al.
Published: (2022-04-01)

Risk factors of first thrombosis in obstetric antiphospholipid syndrome
by: Chun Li, et al.
Published: (2024-01-01)

ANTIPHOSPHOLIPID ANTIBODIES, THEIR PATHOGENETIC AND DIAGNOSTIC ISSUES OBSTETRIC PRACTICE
by: V. O. Bitsadze, et al.
Published: (2016-06-01)

Seronegative Obstetric Antiphospholipid Syndrome Finally Treated Successfully
by: Khawla K Alghanim, et al.
Published: (2022-12-01)

Investigation the complement level in abortive women with antiphospholipid syndrome
by: Manal B. Salih
Published: (2019-07-01)

The Role of Complement Inhibition in Thrombotic Angiopathies and Antiphospholipid Syndrome
by: Doruk Erkan, et al.
Published: (2016-02-01)

LP-069 Update of the epidemiology and mortality of juvenile onset SLE and pediatric SLE in Italy
by: Andrea Doria, et al.
Published: (2023-07-01)

Pathogenesis, Diagnosis and Management of Obstetric Antiphospholipid Syndrome: A Comprehensive Review
by: Jaume Alijotas-Reig, et al.
Published: (2022-01-01)

Effect of L-arginine and aminoguanidine on the cytokine profile in obstetric antiphospholipid syndrome
by: O. Z. Yaremchuk, et al.
Published: (2020-02-01)

Long Term Follow up of Patients With Primary Obstetric Antiphospholipid Syndrome
by: Stanley Niznik, et al.
Published: (2022-04-01)

Early Prediction of Adverse Pregnancy Outcome in Women with Systemic Lupus Erythematosus, Antiphospholipid Syndrome, or Non-Criteria Obstetric Antiphospholipid Syndrome
by: Núria Baños, et al.
Published: (2022-11-01)

Thrombocytopenia in the first trimester predicts adverse pregnancy outcomes in obstetric antiphospholipid syndrome
by: Jiayang Jin, et al.
Published: (2022-08-01)

Pathogenesis of the obstetric antiphospholipid syndrome: the key role of beta 2 glycoprotein I
by: Pier Luigi Meroni, et al.
Published: (2022-08-01)

Profile of antiphospholipid antibodies and complement system in COVID-19 patients of different severity
by: N. V. Dolgushina, et al.
Published: (2022-04-01)

Hemorrhage complications in obstetric antiphospholipid syndrome: Risk factors and association with adverse pregnancy outcomes
by: Yongjing Luo, et al.
Published: (2023-03-01)

LO-041 Severe thrombocytopenia is associated with adverse pregnancy outcomes in obstetric antiphospholipid syndrome
by: Chun Li, et al.
Published: (2023-07-01)

Platelets and the Lectin Pathway of Complement Activation in Patients with Systemic Lupus Erythematosus or Antiphospholipid Syndrome
by: Signe Risbøl Vils, et al.
Published: (2023-04-01)

Deep proteomic analysis of obstetric antiphospholipid syndrome by DIA-MS of extracellular vesicle enriched fractions
by: Wenmin Tian, et al.
Published: (2024-01-01)

PO.2.39 Long term follow up of patients with primary obstetric antiphospholipid syndrome
by: M Ellis, et al.
Published: (2022-10-01)

Confirmation of antiphospholipid antibody positivity: a year’s results in a cohort of 113 patients
by: A. Ruffatti, et al.
Published: (2011-06-01)

P1681: FXI LEVELS AS INDEPENDENT RISK FACTOR FOR THROMBOSIS/OBSTETRIC EVENTS IN PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES
by: M. E. De La Morena-Barrio, et al.
Published: (2022-06-01)

Non-Criteria Obstetric Antiphospholipid Syndrome: How Different Is from Sidney Criteria? A Single-Center Study
by: Víctor M. Martínez-Taboada, et al.
Published: (2022-11-01)

Antiphospholipid syndrome and kidney involvement
by: Emanuele De Simone, et al.
Published: (2023-09-01)

Constitutions and Foreign Relations Law: The Dynamics of Substitutes and Complements
by: Tom Ginsburg
Published: (2017-01-01)

Tolerogenic β2-glycoprotein I DNA vaccine and FK506 as an adjuvant attenuates experimental obstetric antiphospholipid syndrome.
by: Ya-Hsuan Chao, et al.
Published: (2018-01-01)

The Effect of Rituximab on Antiphospholipid Titers in Patients with Antiphospholipid Syndrome
by: Youkhana Youkhana, et al.
Published: (2023-07-01)

Antiphospholipid syndrome
by: Pavlović Dragan M., et al.
Published: (2010-01-01)

An advanced understanding of the heterogeneous clinical features of “non-criteria” obstetric antiphospholipid syndrome: Two case reports and a literature review
by: Xue Peng, et al.
Published: (2023-02-01)

Risk Assessment and Antithrombotic Strategies in Antiphospholipid Antibody Carriers
by: Ilenia Calcaterra, et al.
Published: (2021-01-01)

Antiphospholipide antibodies subtypes in systemic lupus erythematosus and antiphospholipid syndrome
by: T M Reshetnyak, et al.
Published: (2005-10-01)

Immunological markers of antiphospholipid syndrome. Part I – antiphospholipid antibodies
by: E N Alexandrova, et al.
Published: (2009-10-01)

IgA Antiphospholipid Antibodies in Antiphospholipid Syndrome and Systemic Lupus Erythematosus
by: Tatiana Reshetnyak, et al.
Published: (2022-08-01)

Global Antiphospholipid Syndrome Score (GAPSS) in patients with primary antiphospholipid syndrome
by: F. A. Cheldieva, et al.
Published: (2023-02-01)